MedPath

Assessing the neuro-protective effect of mild cooling in neonates receiving extra-corporeal membrane oxygenation (ECMO)

Completed
Conditions
Fully grown newborn babies requiring help with their breathing and circulation.
Neonatal Diseases
Respiratory
Registration Number
ISRCTN72635512
Lead Sponsor
niversity Hospitals of Leicester NHS Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
118
Inclusion Criteria

Babies recruited to the study must be the existing standard criteria for ECMO eligibility.
These include:
1. To be at least 35 weeks gestation
2. To be at least 2000 g birth weight
3. To have no uncontrolled bleeding disorder
4. To have no congenital or acquired central nervous system (CNS) disorder
5. To have undergone no more than 7 consecutive days of high pressure ventilation prior to referral for ECMO
6. To be suffering from a condition which is potentially reversible
7. To have evidence of severe cardio respiratory failure
8. Less than 29 days of age, either sex

Exclusion Criteria

1. All neonates referred with diaphragmatic hernia
2. All neonates receiving ECMO for post operative cardiac support

Added 19/05/10:
3. All neonates who have been cooled prior to ECMO

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Current information as of 19/05/10:<br>Cognitive score from the Bayley scales of Infant and toddler Development, 3rd edition (Bayley-III) at age of 2 years (24 - 27 months)<br><br>Initial information at time of registration:<br>The Mental Development Index (MDI) of the Bayley scales of the surviving children in each arm of the study at the age of 2 years (24 - 27 months)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath